Skip to main content

How would a decision to leave the European Union affect medical research and health in the United Kingdom?

In an article published in the Journal of the Royal Society of Medicine, I argue that the UK must remain in the European Union (EU) to protect the health of UK residents. Also at risk following a vote to leave the EU would be the recruitment of doctors and healthcare workers to the NHS, medical research and teaching and the continued world-leading status of the top UK universities.

The most important impact of a ‘leave’ vote on health would arise from its economic effects, A Treasury analysis concluded a vote to leave the EU could lead to a £36 billion a year drop in tax receipts. The economic shockwaves following a departure from the EU could lead to substantial cuts to health and social care, and there would be an immediate negative impact on the health of UK residents. Lower levels of spending on social care would further increase pressures on both community and hospital services. For example, it would become more difficult to discharge frail, elderly patients from hospitals.

In the article, I also express concern about the impact on the NHS workforce of an EU exit. Currently around 50,000 people from the European Economic Area, including 9,000 doctors, provide a vital contribution to the NHS by plugging the gap left by key shortages in its workforce. The EU has established standards across member states for the training of doctors and health professionals. A vote to leave the EU would make future recruitment more difficult as the UK would have to negotiate with each EU country separately to ensure that doctors and other health professionals recruited to work in the UK are trained to the same standards expected from UK-trained staff.

Residents of the UK who visit other EU countries either as tourists or on business would lose their right to free or low-cost health care, which is currently obtained via the European Health Insurance Card. The right to publicly-funded healthcare of the two million citizens of the UK who live permanently in other European countries would also come under threat. The UK government would also be under no obligation to implement European-wide public health initiatives if the UK was no longer a member. These have had a major positive impact in areas such as food regulations, road safety, air pollution, tobacco control and chemical hazards.

The key role the UK plays in cross-national research projects, including many in health-related fields, would also be at risk. The UK currently engages very heavily with other member states of the European Union and with European institutions over many health-related and scientific issues. A vote to leave the EU would start an extremely complex programme of negotiations, lasting many years and with uncertain outcomes, that would threaten these positive collaborations. Given the very large potential negative effects of an exit from the European Union, doctors, health professionals, academics and their professional organisations should all be concerned about its consequences.

The full article can be viewed on the Journal of the Royal Society of Medicine website.

The article was covered by the BMJ and GP.

Coverage on social media can be viewed on Altmetric.


Popular posts from this blog

Improving discharge planning in NHS hospitals

Factors that need to be considered in discharge planning that have been identified in previous projects include:

Ensuring that discharge arrangements are discussed with patients, family members and carers; and that they are given a copy of the discharge summary.Adequate coordination between the hospital, community health services, general practices, and the providers of social care services.There is a follow-up after discharge of patients at high risk of complications or readmission - either in person or by telephone - to ensure that the discharge arrangements are working well. Medicines reconciliation is carried out. This is the process of verifying patient medication lists at a point-of-care transition, such as hospital discharge, to identify which medications have been added, discontinued, or changed from pre-admission medication lists.Ensuring that any outstanding test results at discharge are obtained and passed on to primary care teams; and ensuring there are clear arrangements …

Can GPs issue private prescriptions to NHS patients?

The NHS prescription charge in England is currently £8.40 per item. At this level, many commonly prescribed drugs will cost less than the prescription charge and so some NHS patients may occasionally ask if they can have a private prescription rather than an NHS prescription.

In the past, some GPs have been advised that they could issue both an NHS FP10 and a private prescription, and let the patient decide which to use. But the British Medical Association's General Practice Committee has obtained legal advice that said under the current primary care contract, GPs in England may not issue a private prescription alongside or as an alternative to an NHS FP10 prescription. In any consultation where a GP needs to issue an FP10, the concurrent issue of a private prescription would be a breach of NHS regulations.

The issuing of a private prescription in such circumstances could also be seen as an attempt to deprive the NHS of the funds it would receive from the prescription charge. Fur…

What impact will Brexit have on the UK's life sciences sector?

On Thursday 3 November 2016, I spoke at a seminar at the Imperial College Business School on the topic of the impact of Brexit on the UK's life sciences sector (the NHS, universities, and pharmaceutical and biomedical companies). I emphasised the important role played in the life sciences sector by EU-trained professionals and the need to ensure that the UK continued to attract highly-qualified professionals to work, for example, in our National Health Service. I also discussed the need to increase spending on research and development to ensure that the UK remained a world leader in the biomedical industry. The other speakers at the seminar were Andrew Lansley (former Secretary of State for Health) and Richard Phillips (Director of Healthcare Policy at the Association of British Healthcare industries). The event was chaired by Andrew Brown. A copy of my talk can be viewed on Slideshare.